SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-009490
Filing Date
2018-07-05
Accepted
2018-07-05 16:44:58
Documents
2
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1742
2 zeldinpoa.txt EX-24 3303
  Complete submission text file 0001179110-18-009490.txt   6389
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Zeldin Robert K (Reporting) CIK: 0001745347 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36065 | Film No.: 18941055